Sage Therapeutics Inc - Company Profile
Powered by 
All the sales intelligence you need on Sage Therapeutics Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Sage Therapeutics Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Sage Therapeutics Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
The following section provides information on Sage Therapeutics Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Sage Therapeutics Inc's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Geno Germano
Chairman Executive BoardMr. Geno Germano has been the Chairman of the company since January 2024. Prior to this, he served on the Board of Directors of the company. Mr. Germano also serves as the President and Chief Executive Officer of Elucida Oncology. He has experience in the pharmaceutical industry and held leadership roles at Intrexon, Pfizer, Wyeth, and Johnson & Johnson.
Barry E. Greene
Chief Executive Officer; Director; President Executive BoardMr. Barry E. Greene has been the Chief Executive Officer, President, and Director of the company since 2020. Prior to this, he served as the President of Alnylam Pharmaceuticals Inc from 2007 to September 2020. Mr. Greene also served as the Chief Operating Officer of Alnylam Pharmaceuticals Inc from 2003 to 2016. Previously, he served as the General Manager of Oncology at Millennium Pharmaceuticals Inc.
Christopher Benecchi
Chief Operating Officer Senior ManagementMr. Christopher Benecchi has been the Chief Operating Officer of the company since October 2024. Prior to this, he served as the Chief Business Officer of the company since 2022. Previously, he served as the Vice President, Global Head of Commercial Excellence at Alexion. Mr. Benecchi also served in various commercial roles of increasing responsibility at UCB Inc including Global Launch Head, Commercial and Medical Affairs, Immunology; Global Commercial Strategy Lead, Immunology; and Global Marketing Head.
Laura Gault, MD, Ph.D
Chief Medical Officer Senior ManagementMs. Laura Gault has been the Chief Medical Officer of the company since 2022. Prior to this, she served as the Vice President, Neurology Clinical Development at Alexion Pharmaceuticals Inc. Previously, she served as the Vice President, Neurology Clinical Development at Vertex Pharmaceuticals from August 2017 to March 2019.
Michael Quirk, Ph.D.
Chief Scientific Officer Senior ManagementMr. Michael Quirk has been the Chief Scientific Officer of the company since September 2023. Prior to this, he served as the Senior Vice President of the company. Previously, he served as the Director of AstraZeneca. Mr. Quirk also served as the Senior Scientist of AstraZeneca R&D.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer